Frank Takkinen
Stock Analyst at Lake Street
(2.00)
# 2,967
Out of 4,761 analysts
49
Total ratings
38.78%
Success rate
-5.74%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $19.12 | +35.98% | 3 | Feb 14, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $16.72 | +79.43% | 4 | Jan 21, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $5 → $3 | $2.53 | +18.58% | 2 | Jan 15, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $3.71 | +34.77% | 2 | Jan 14, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $20 | $8.25 | +142.42% | 1 | Jan 8, 2025 | |
| NSPR InspireMD | Initiates: Buy | $5 | $3.19 | +56.74% | 1 | Dec 11, 2024 | |
| CVRX CVRx, Inc. | Maintains: Buy | $12 → $15 | $13.85 | +8.30% | 6 | Oct 30, 2024 | |
| NOTV Inotiv | Upgrades: Buy | $2 → $4 | $4.06 | -1.48% | 6 | Sep 30, 2024 | |
| TELA TELA Bio | Maintains: Buy | $14 → $8 | $2.72 | +194.12% | 2 | Aug 13, 2024 | |
| AORT Artivion | Maintains: Buy | $28 → $30 | $28.26 | +6.16% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $3.22 | +210.56% | 2 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $8.96 | +33.93% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.48 | +305.41% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.20 | +81.82% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $13.77 | -12.85% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $177.32 | +97.38% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $2.70 | +85.19% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.51 | +496.03% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.58 | +520.16% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.79 | +1,065.70% | 2 | Jan 18, 2023 |
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $19.12
Upside: +35.98%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $16.72
Upside: +79.43%
Sight Sciences
Jan 15, 2025
Maintains: Hold
Price Target: $5 → $3
Current: $2.53
Upside: +18.58%
KORU Medical Systems
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.71
Upside: +34.77%
Anteris Technologies Global
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $8.25
Upside: +142.42%
InspireMD
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $3.19
Upside: +56.74%
CVRx, Inc.
Oct 30, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $13.85
Upside: +8.30%
Inotiv
Sep 30, 2024
Upgrades: Buy
Price Target: $2 → $4
Current: $4.06
Upside: -1.48%
TELA Bio
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $2.72
Upside: +194.12%
Artivion
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $28.26
Upside: +6.16%
Jun 21, 2024
Maintains: Buy
Price Target: $5 → $10
Current: $3.22
Upside: +210.56%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $8.96
Upside: +33.93%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.48
Upside: +305.41%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.20
Upside: +81.82%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $13.77
Upside: -12.85%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $177.32
Upside: +97.38%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $2.70
Upside: +85.19%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.51
Upside: +496.03%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.58
Upside: +520.16%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.79
Upside: +1,065.70%